Cargando…

The Relationship Between PD-1(rs2227981) and PD-L1(rs2890658) Polymorphisms and Urothelial Cell Carcinoma

Background Urothelial cell carcinoma, which is believed to develop from the urothelium (transitional epithelium), is the most common aggressive tumor and accounts for the ten most prevalent cancers in the world. The risk factors for urothelial cell carcinoma are aging, smoking, gender, and genetic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hlaing, Sa Tin Myo, Damayanti, Putri, Zin Aung, Khine, Tsukino, Hiromasa, Hinoura, Takuji, Kuroda, Yoshiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693471/
https://www.ncbi.nlm.nih.gov/pubmed/38046711
http://dx.doi.org/10.7759/cureus.48120
_version_ 1785153168759324672
author Hlaing, Sa Tin Myo
Damayanti, Putri
Zin Aung, Khine
Tsukino, Hiromasa
Hinoura, Takuji
Kuroda, Yoshiki
author_facet Hlaing, Sa Tin Myo
Damayanti, Putri
Zin Aung, Khine
Tsukino, Hiromasa
Hinoura, Takuji
Kuroda, Yoshiki
author_sort Hlaing, Sa Tin Myo
collection PubMed
description Background Urothelial cell carcinoma, which is believed to develop from the urothelium (transitional epithelium), is the most common aggressive tumor and accounts for the ten most prevalent cancers in the world. The risk factors for urothelial cell carcinoma are aging, smoking, gender, and genetic alternations. Programmed cell death1 (PD-1) has been widely described as a negative regulator of T-cells by sending inhibitory signals to the T-cell. Through PD-1 binding with PD-L1 (ligand for PD-1), an inhibitory signal is propagated to the T cell. The polymorphisms of PD-1 and PD-L1 lead to an efficient T-cell response and affect an anti-tumor reaction. The polymorphisms of PD-1 and PD-L1 could also affect the carcinogenesis of human cancer, including urothelial cell carcinoma. Therefore, in this study, we evaluated the relation between PD-1(rs2227981) and PD-L1(rs2890658) polymorphisms and the carcinogenesis of urothelial cell carcinoma. Materials and methods This study was conducted using 211 healthy controls and 256 cases of urothelial cell carcinoma among the Japanese population. The DNA samples were extracted from the peripheral white blood cells of each subject. The genotype was detected by using the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) method. Results C/T (Adjusted OR 1.55, 95% CI:1.02-2.35) and C/T+T/T (OR 1.46, 95% CI:1.01-2.12) genotypes of PD-1 rs2227981 were significant and risk factors for urothelial cancer. Male with A/A genotype in PD-L1 and CT genotype in PD-1 has a significant higher risk factor compared with other genotypes (Adjusted OR 1.83, 95% CI:1.05-3.21). Conclusions and discussion We found that C/T(PD-1) and “A/A (PD-L1) and C/T(PD-1)” were predominant in urothelial cell carcinoma cases. This indicates that C/T(PD-1) and “A/A (PD-L1) and C/T(PD-1)” genotypes could increase susceptibility to urothelial cell carcinoma. However, since our findings indicated that the effects of PD-1 and PD-L1 polymorphisms included discrepancies, additional research will be needed to evaluate the relationship between human cancer and PD-1 and PD-L1 polymorphisms. This is the first study that seeks to find the relation between PD-1(rs2227981) and PD-L1(rs2890658) polymorphisms concerning urothelial cell carcinoma among the Japanese population.
format Online
Article
Text
id pubmed-10693471
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-106934712023-12-03 The Relationship Between PD-1(rs2227981) and PD-L1(rs2890658) Polymorphisms and Urothelial Cell Carcinoma Hlaing, Sa Tin Myo Damayanti, Putri Zin Aung, Khine Tsukino, Hiromasa Hinoura, Takuji Kuroda, Yoshiki Cureus Epidemiology/Public Health Background Urothelial cell carcinoma, which is believed to develop from the urothelium (transitional epithelium), is the most common aggressive tumor and accounts for the ten most prevalent cancers in the world. The risk factors for urothelial cell carcinoma are aging, smoking, gender, and genetic alternations. Programmed cell death1 (PD-1) has been widely described as a negative regulator of T-cells by sending inhibitory signals to the T-cell. Through PD-1 binding with PD-L1 (ligand for PD-1), an inhibitory signal is propagated to the T cell. The polymorphisms of PD-1 and PD-L1 lead to an efficient T-cell response and affect an anti-tumor reaction. The polymorphisms of PD-1 and PD-L1 could also affect the carcinogenesis of human cancer, including urothelial cell carcinoma. Therefore, in this study, we evaluated the relation between PD-1(rs2227981) and PD-L1(rs2890658) polymorphisms and the carcinogenesis of urothelial cell carcinoma. Materials and methods This study was conducted using 211 healthy controls and 256 cases of urothelial cell carcinoma among the Japanese population. The DNA samples were extracted from the peripheral white blood cells of each subject. The genotype was detected by using the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) method. Results C/T (Adjusted OR 1.55, 95% CI:1.02-2.35) and C/T+T/T (OR 1.46, 95% CI:1.01-2.12) genotypes of PD-1 rs2227981 were significant and risk factors for urothelial cancer. Male with A/A genotype in PD-L1 and CT genotype in PD-1 has a significant higher risk factor compared with other genotypes (Adjusted OR 1.83, 95% CI:1.05-3.21). Conclusions and discussion We found that C/T(PD-1) and “A/A (PD-L1) and C/T(PD-1)” were predominant in urothelial cell carcinoma cases. This indicates that C/T(PD-1) and “A/A (PD-L1) and C/T(PD-1)” genotypes could increase susceptibility to urothelial cell carcinoma. However, since our findings indicated that the effects of PD-1 and PD-L1 polymorphisms included discrepancies, additional research will be needed to evaluate the relationship between human cancer and PD-1 and PD-L1 polymorphisms. This is the first study that seeks to find the relation between PD-1(rs2227981) and PD-L1(rs2890658) polymorphisms concerning urothelial cell carcinoma among the Japanese population. Cureus 2023-11-01 /pmc/articles/PMC10693471/ /pubmed/38046711 http://dx.doi.org/10.7759/cureus.48120 Text en Copyright © 2023, Hlaing et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Epidemiology/Public Health
Hlaing, Sa Tin Myo
Damayanti, Putri
Zin Aung, Khine
Tsukino, Hiromasa
Hinoura, Takuji
Kuroda, Yoshiki
The Relationship Between PD-1(rs2227981) and PD-L1(rs2890658) Polymorphisms and Urothelial Cell Carcinoma
title The Relationship Between PD-1(rs2227981) and PD-L1(rs2890658) Polymorphisms and Urothelial Cell Carcinoma
title_full The Relationship Between PD-1(rs2227981) and PD-L1(rs2890658) Polymorphisms and Urothelial Cell Carcinoma
title_fullStr The Relationship Between PD-1(rs2227981) and PD-L1(rs2890658) Polymorphisms and Urothelial Cell Carcinoma
title_full_unstemmed The Relationship Between PD-1(rs2227981) and PD-L1(rs2890658) Polymorphisms and Urothelial Cell Carcinoma
title_short The Relationship Between PD-1(rs2227981) and PD-L1(rs2890658) Polymorphisms and Urothelial Cell Carcinoma
title_sort relationship between pd-1(rs2227981) and pd-l1(rs2890658) polymorphisms and urothelial cell carcinoma
topic Epidemiology/Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693471/
https://www.ncbi.nlm.nih.gov/pubmed/38046711
http://dx.doi.org/10.7759/cureus.48120
work_keys_str_mv AT hlaingsatinmyo therelationshipbetweenpd1rs2227981andpdl1rs2890658polymorphismsandurothelialcellcarcinoma
AT damayantiputri therelationshipbetweenpd1rs2227981andpdl1rs2890658polymorphismsandurothelialcellcarcinoma
AT zinaungkhine therelationshipbetweenpd1rs2227981andpdl1rs2890658polymorphismsandurothelialcellcarcinoma
AT tsukinohiromasa therelationshipbetweenpd1rs2227981andpdl1rs2890658polymorphismsandurothelialcellcarcinoma
AT hinouratakuji therelationshipbetweenpd1rs2227981andpdl1rs2890658polymorphismsandurothelialcellcarcinoma
AT kurodayoshiki therelationshipbetweenpd1rs2227981andpdl1rs2890658polymorphismsandurothelialcellcarcinoma
AT hlaingsatinmyo relationshipbetweenpd1rs2227981andpdl1rs2890658polymorphismsandurothelialcellcarcinoma
AT damayantiputri relationshipbetweenpd1rs2227981andpdl1rs2890658polymorphismsandurothelialcellcarcinoma
AT zinaungkhine relationshipbetweenpd1rs2227981andpdl1rs2890658polymorphismsandurothelialcellcarcinoma
AT tsukinohiromasa relationshipbetweenpd1rs2227981andpdl1rs2890658polymorphismsandurothelialcellcarcinoma
AT hinouratakuji relationshipbetweenpd1rs2227981andpdl1rs2890658polymorphismsandurothelialcellcarcinoma
AT kurodayoshiki relationshipbetweenpd1rs2227981andpdl1rs2890658polymorphismsandurothelialcellcarcinoma